New Diagnostic Possibilities for Neonatal Sepsis
- 25 April 2018
- journal article
- research article
- Published by Georg Thieme Verlag KG in American Journal of Perinatology
- Vol. 35 (06) , 575-577
Abstract
Progress in neonatal care has decrease morbidity and mortality due to neonatal sepsis (NS). Although diagnosis of sepsis continues to rely on blood culture, this method is too slow and limited by false-negative results. There are numerous sepsis biomarkers that have been evaluated for the early diagnosis of NS, but, to date, there is no single ideal biomarker, though novel biomarkers are becoming more sophisticated and specific in their clinical applications. This review provides an overview of the current diagnostic approaches available or under development for diagnosing NS.Keywords
This publication has 15 references indexed in Scilit:
- Molecular assays for the diagnosis of sepsis in neonatesCochrane Database of Systematic Reviews, 2017
- Cord Blood Acute Phase Reactants Predict Early Onset Neonatal Sepsis in Preterm InfantsPLOS ONE, 2017
- Utility of cytokines to predict neonatal sepsisPediatric Research, 2016
- Presepsin for the detection of early-onset sepsis in preterm newbornsPediatric Research, 2016
- Meta-analysis of diagnostic accuracy of neutrophil CD64 for neonatal sepsisItalian Journal of Pediatrics, 2016
- Neutrophil CD64 combined with PCT, CRP and WBC improves the sensitivity for the early diagnosis of neonatal sepsisClinical Chemistry and Laboratory Medicine (CCLM), 2016
- Presepsin (Soluble CD14 Subtype): Reference Ranges of a New Sepsis Marker in Term and Preterm NeonatesPLOS ONE, 2015
- Interleukin-8 for Diagnosis of Neonatal Sepsis: A Meta-AnalysisPLOS ONE, 2015
- Presepsin for the Detection of Late-Onset Sepsis in Preterm NewbornsPediatrics, 2015
- Urinary 1H-NMR and GC-MS metabolomics predicts early and late onset neonatal sepsisEarly Human Development, 2014